Osaic Holdings’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.5K | Buy |
14,875
+12,991
| +690% | +$4.81K | ﹤0.01% | 6072 |
|
|
2025
Q1 | $3.82K | Buy |
1,884
+954
| +103% | +$1.94K | ﹤0.01% | 6208 |
|
|
2024
Q4 | $5.5K | Buy |
930
+399
| +75% | +$2.36K | ﹤0.01% | 6044 |
|
|
2024
Q3 | $5.19K | Buy |
531
+242
| +84% | +$2.36K | ﹤0.01% | 6064 |
|
|
2024
Q2 | $5.93K | Buy |
289
+218
| +307% | +$4.47K | ﹤0.01% | 5988 |
|
|
2024
Q1 | $3.19K | Buy |
71
+44
| +163% | +$1.97K | ﹤0.01% | 6155 |
|
|
2023
Q4 | $1.27K | Buy |
27
+8
| +42% | +$376 | ﹤0.01% | 6528 |
|
|
2023
Q3 | $759 | Sell |
19
-117
| -86% | -$4.67K | ﹤0.01% | 6749 |
|
|
2023
Q2 | $14.4K | Buy |
136
+25
| +23% | +$2.65K | ﹤0.01% | 5735 |
|
|
2023
Q1 | $33.1K | Sell |
111
-52
| -32% | -$15.5K | ﹤0.01% | 5232 |
|
|
2022
Q4 | $56K | Sell |
163
-15
| -8% | -$5.15K | ﹤0.01% | 4839 |
|
|
2022
Q3 | $34K | Sell |
178
-41
| -19% | -$7.83K | ﹤0.01% | 5185 |
|
|
2022
Q2 | $47K | Sell |
219
-24
| -10% | -$5.15K | ﹤0.01% | 4996 |
|
|
2022
Q1 | $94K | Buy |
243
+28
| +13% | +$10.8K | ﹤0.01% | 4635 |
|
|
2021
Q4 | $70K | Sell |
215
-743
| -78% | -$242K | ﹤0.01% | 4878 |
|
|
2021
Q3 | $465K | Buy |
958
+84
| +10% | +$40.8K | ﹤0.01% | 3104 |
|
|
2021
Q2 | $406K | Buy |
874
+255
| +41% | +$118K | ﹤0.01% | 3234 |
|
|
2021
Q1 | $428K | Buy |
619
+340
| +122% | +$235K | ﹤0.01% | 3037 |
|
|
2020
Q4 | $206K | Buy |
279
+63
| +29% | +$46.5K | ﹤0.01% | 3453 |
|
|
2020
Q3 | $152K | Buy |
216
+124
| +135% | +$87.3K | ﹤0.01% | 3489 |
|
|
2020
Q2 | $78K | Sell |
92
-22
| -19% | -$18.7K | ﹤0.01% | 3860 |
|
|
2020
Q1 | $39K | Buy |
+114
| New | +$39K | ﹤0.01% | 4135 |
|